189 related articles for article (PubMed ID: 3546145)
1. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.
Vanhoof R; Hubrechts JM; Roebben E; Nyssen HJ; Nulens E; Leger J; De Schepper N
Infection; 1986; 14(6):294-8. PubMed ID: 3546145
[TBL] [Abstract][Full Text] [Related]
2. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Habiyaremye I; Verbist L; Vandepitte J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
[TBL] [Abstract][Full Text] [Related]
3. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Renaudin H; Quentin C; de Barbeyrac B; Bebear C
Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Edlund C; Nord CE
Scand J Infect Dis; 1986; 18(2):149-51. PubMed ID: 2939556
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Clarke AM; Zemcov SJ; Campbell ME
J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
Van der Auwera P
Infection; 1986; 14(3):142-4. PubMed ID: 2942489
[TBL] [Abstract][Full Text] [Related]
9. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of newer quinolones against aerobic bacteria.
Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Barry AL; Jones RN
Eur J Clin Microbiol; 1987 Apr; 6(2):179-82. PubMed ID: 3474145
[TBL] [Abstract][Full Text] [Related]
12. [Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].
Le Noc P; Croizé J; Le Noc D
Pathol Biol (Paris); 1993 Apr; 41(4):294-301. PubMed ID: 8233625
[TBL] [Abstract][Full Text] [Related]
13. In-vitro selection of bacteria resistant to the 4-quinolone agents.
Limb DI; Dabbs DJ; Spencer RC
J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Hannan A
Curr Med Res Opin; 1992; 12(9):560-3. PubMed ID: 1316257
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of eight antibiotics against Salmonella and Shigella species.
Arman D; Willke A; Tural D
Eur J Epidemiol; 1994 Jun; 10(3):345-7. PubMed ID: 7859848
[TBL] [Abstract][Full Text] [Related]
16. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Davies S; Sparham PD; Spencer RC
J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
[TBL] [Abstract][Full Text] [Related]
17. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
18. [In vitro antibacterial activity of new derivatives of pyridonecarboxylic acid, norfloxacin, ofloxacin, enoxacin and ciprofloxacin, against Vibrio cholerae O-1].
Matsushita S; Yamada S; Kudoh Y; Ohashi M
Kansenshogaku Zasshi; 1987 Mar; 61(3):292-6. PubMed ID: 3112282
[No Abstract] [Full Text] [Related]
19. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Delmee M; Avesani V
Antimicrob Agents Chemother; 1986 Feb; 29(2):374-5. PubMed ID: 2940968
[TBL] [Abstract][Full Text] [Related]
20. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Shrire L; Saunders J; Traynor R; Koornhof HJ
Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]